1337882-50-4

Usage

Uses

Used in Pharmaceutical Industry:
6-(Benzyloxy)-3-bromoquinoline is used as a building block in the synthesis of pharmaceuticals and organic compounds. Its unique structure and properties make it a valuable component in the development of new drugs and medicinal agents.
Used in Chemical Industry:
6-(Benzyloxy)-3-bromoquinoline is utilized in various chemical applications due to its versatile chemical properties. It serves as an intermediate in the synthesis of other organic compounds, contributing to the advancement of chemical research and development.
Used in Bioimaging Studies:
6-(Benzyloxy)-3-bromoquinoline is employed as a fluorescent probe in bioimaging studies. Its unique optical properties allow for the visualization and tracking of biological processes, providing valuable insights into cellular and molecular mechanisms.
Used in Drug Discovery and Development:
6-(Benzyloxy)-3-bromoquinoline has potential medicinal properties and may be used in drug discovery and development. Its diverse applications and unique characteristics make it a promising candidate for the identification and development of new therapeutic agents.

Upstream product

• 108825-21-4 6-(benzyloxy)quinoline 
• 1022151-47-8 3-bromoquinolin-6-yl acetate 
• 24306-33-0 methyl quinolin-6-ylethanoate 
• 580-16-5 6-hydroxyquinoline 
• 13669-57-3 3-bromo-6-hydroxyquinoline 
• 100-39-0 benzyl bromide 

Downstream Products

• 1393352-90-3 (S)-1-(6-(benzyloxy)quinolin-3-yl)-N,N-dimethylpyrrolidin-3-amine 
• 1393352-93-6 N-((6-(benzyloxy)quinolin-3-yl)methyl)-N-ethylethanamine 
• 1427473-83-3 1-((6-(benzyloxy)naphthalen-3-yl)methyl)-4-methylpiperazine 
• 1427474-57-4 4-(6-(benzyloxy)quinolin-3-yl)-3-methylmorpholine 
• 1427474-53-0 N-benzyl-6-(benzyloxy)quinolin-3-amine 
• 1427474-50-7 6-(benzyloxy)-N-(2-(tert-butyldimethylsilyloxy)ethyl)quinolin-3-amine 
• 1427473-97-9 6-(benzyloxy)-3-(4-methyl-1,4-diazepan-1-yl)quinoline 
• 727650-61-5 3-aminoquinolin-6-ol 

Relevant academic research and scientific papers

Synthesis and antibacterial activity of novel ketolides with 11,12-quinoylalkyl side chains

A series of quinoylalkyl side chains was designed and synthesized, followed by introduction into ketolides by coupling with building block 6 or 32. The corresponding targets 7a–n, 33b, and 33e were tested for their in vitro activities against a series of macrolide-sensitive and macrolide-resistant pathogens. Some of them showed a similar antibacterial spectrum and comparable activity to telithromycin. Among them, two C2-F ketolides, compounds 33b and 33e, displayed excellent activities against macrolide-sensitive and macrolide-resistant pathogens.

Pyrazolo [1, 5 - a] pyrimidine compounds and their preparation method and medical use

The invention relates to a pyrazolo[1,5-a]miazine compound and its preparation method and medical use. The invention relates to the preparation method of the pyrazolo[1,5-a]miazine compound shown in the general formula (I) and its salt, a pharmaceutical c

6 - SUBSTITUTED 3 - (QUINOLIN- 6 - YLTHIO) - [1,2,4] TRIAZOLO [4, 3 -A] PYRADINES AS TYROSINE KINASE

The invention relates to compounds of formula (I) and salts thereof: Formula (I) wherein the substituents are as defined in the specification; a compound of formula (I) for use in the treatment of the human or animal body, in particular with regard to c-Met tyrosine kinase mediated diseases or conditions; the use of a compound of formula (I) for manufacturing a medicament for the treatment of such diseases; pharmaceutical compositions comprising a compound of the formula (I), optionally in the presence of a combination partner, and processes for the preparation of a compound of formula (I).

TRIAZOLOPYRIDINE COMPOUNDS

The invention relates to compounds of formula (I) and salts thereof: wherein the substituents are as defined in the specification; a compound of formula (I) for use in the treatment of the human or animal body, in particular with regard to c-Met tyrosine kinase mediated diseases or conditions; the use of a compound o f formula (I) for manufacturing a medicament for the treatment of such diseases; pharmaceutical compositions comprising a compound of the formula (I), optionally in the presence of a combination partner, and processes for the preparation of a compound of formula (I)

[1,2,4] TRIAZOLO [4,3-B] PYRIDAZINE COMPOUNDS AS INHIBITORS OF THE C-MET TYROSINE KINASE

The invention relates to compounds of formula (I) and salts thereof: wherein the substituents are as defined in the specification; a compound of formula (I) for use in the treatment of the human or animal body, in particular with regard to c-Met tyrosine kinase mediated diseases or conditions; the use of a compound of formula (I) for manufacturing a medicament for the treatment of such diseases; pharmaceutical compositions comprising a compound of the formula (I), optionally in the presence of a combination partner, and processes for the preparation of a compound of formula (I).

[1, 2, 4] TRIAZOLO [4, 3 -B] PYRIDAZINE COMPOUNDS AS INHIBITORS OF THE C-MET TYROSINE KINASE

The invention relates to compounds of formula (I) and salts thereof: wherein the substituents are as defined in the specification; a compound of formula (I) for use in the treatment of the human or animal body, in particular with regard to c-Met tyrosine kinase mediated diseases or conditions; the use of a compound of formula (I) for manufacturing a medicament for the treatment of such diseases; pharmaceutical compositions comprising a compound of the formula (I), optionally in the presence of a combination partner, and processes for the preparation of a compound of formula (I).